Table 1 Baseline characteristics of study population

Number

657

423

464

Sex (M/F)

256/401

174/249

205/259

Age (years)

47.0 (36.0, 54.0)

52.0 (44.0, 58.0)^a

59.0 (50.0, 65.0)^{a, b}

SBP (mmHg)

121.0 (119.0, 122.0)

126.0 (124.0, 127.0)^a

129.0 (127.0, 131.0)^{a, b}

DBP (mmHg)

76.0 (75.0, 77.0)

79.0 (78.0, 80.0)^a

79.0 (78.0, 80.0)^a

BMI (kg/m2)

24.39 (24.03, 24.75)

25.12 (24.68, 25.55)^a

25.26 (24.81, 25.70)^a

WC (cm)

83.0 (82.1, 83.9)

88.4 (87.3, 89.5)^a

92.2 (91.1, 93.3)^{a, b}

VAI

1.70 (1.53, 1.87)

2.39 (2.19, 2.59)^a

2.82 (2.62, 3.03)^{a, b}

TyG

8.43 (8.38, 8.48)

8.81 (8.75, 8.87)^a

9.21 (9.15, 9.27)^{a, b}

TyG-BMI

206.47 (202.86, 210.08)

222.05 (217.69, 226.42)^a

233.45 (228.99, 237.91)^{a, b}

TyG-WC

702.07 (692.13, 712.00)

780.36 (768.35, 792.37)^a

851.94 (839.66, 864.22)^{a, b}

TG (mmol/L)

1.33 (1.23, 1.43)

1.71 (1.59, 1.82)^a

1.94 (1.82, 2.07)^{a, b}

TC (mmol/L)

4.92 (4.83, 5.00)

5.01 (4.91, 5.11)

5.09 (4.98, 5.19)^a

HDL-C (mmol/L)

1.47 (1.44, 1.50)

1.31 (1.27, 1.35)^a

1.31 (1.27, 1.34)^a

LDL-C (mmol/L)

2.93 (2.87, 2.99)

3.03 (2.96, 3.10)^a

3.06 (2.98, 3.13)^a

FPG (mmol/L)

5.10 (4.97, 5.22)

5.74 (5.59, 5.89)^a

8.65 (8.50, 8.81)^{a, b}

2hPG (mmol/L)

6.06 (5.83, 6.29)

8.65 (8.38, 8.93)^a

17.11 (16.83, 17.39)^{a, b}

FINS (μU/ml)

9.23 (8.55, 9.92)

11.19 (10.36, 12.03)^a

12.58 (11.73, 13.43)^{a, b}

2hINS (μU/ml)

38.70 (36.09, 41.31)

65.52 (62.36, 68.68)^a

43.02 (39.80, 46.25)^b

HbA1c (%)

5.50 (5.42, 5.58)

5.75 (5.65, 5.84)^a

7.36 (7.27, 7.46)^{a, b}